1. Home
  2. RIV vs EMBC Comparison

RIV vs EMBC Comparison

Compare RIV & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RiverNorth Opportunities Fund Inc.

RIV

RiverNorth Opportunities Fund Inc.

N/A

Current Price

$10.24

Market Cap

315.3M

Sector

Finance

ML Signal

N/A

Logo Embecta Corp.

EMBC

Embecta Corp.

N/A

Current Price

$6.18

Market Cap

354.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RIV
EMBC
Founded
2015
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
315.3M
354.1M
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
RIV
EMBC
Price
$10.24
$6.18
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
★ $4.00
AVG Volume (30 Days)
122.1K
★ 826.2K
Earning Date
01-01-0001
11-24-2026
Dividend Yield
★ 12.85%
0.63%
EPS Growth
N/A
★ 20.90
EPS
N/A
★ 1.03
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$5.59
P/E Ratio
★ N/A
$6.33
Revenue Growth
N/A
N/A
52 Week Low
$9.82
$2.77
52 Week High
$12.15
$14.91

Technical Indicators

Market Signals
Indicator
RIV
EMBC
Relative Strength Index (RSI) 49.11 49.08
Support Level $9.83 $3.01
Resistance Level $10.72 $6.90
Average True Range (ATR) 0.21 0.34
MACD 0.04 -0.08
Stochastic Oscillator 56.06 32.59

Price Performance

Historical Comparison
RIV
EMBC

About RIV RiverNorth Opportunities Fund Inc.

Rivernorth Opportunities Fund Inc is a diversified, closed-end management investment company. Its investment objective is total return consisting of capital appreciation and current income. The Fund employs a tactical asset allocation plan focused on closed-end funds (CEFs), exchange-traded funds (ETFs), special purpose acquisition companies (SPACs), and business development companies (BDCs). The majority of its portfolio is invested in closed-end funds (CEFs).

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: